This announcement is a separate document:
加科思-B:自願公告 加科思宣佈其P53 Y220C激活劑JAB-30300新藥臨床實驗申請(IND)在美國獲批
JACOBIO-B: VOLUNTARY ANNOUNCEMENTJACOBIO RECEIVED US FDA INVESTIGATIONALNEW DRUG CLEARANCE FOR P53 Y220C Activator JAB-30300
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.